AMR vs Korea: Hypertension treatment coverage among adults aged 30-79 with
AMR
62.0%
in 2019
Korea
74.7%
in 2019
AMR rank
2nd
Korea rank
2nd
Hypertension treatment coverage among adults aged 30-79 with over time
- AMR
- Korea
How they compare
Korea currently reports 74.7% against 62.0% in AMR, a difference of 12.7%.
That makes Korea's figure about 1.2 times AMR's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was AMR ahead.
AMR ranks 2nd and Korea ranks 2nd of 17 groups.
Across the 3 decades both report, AMR averaged higher in 2 and Korea in 1.
Head to head by decade
| Decade | AMR | Korea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 43.5% | 29.3% | 14.2% | AMR |
| 2000s | 53.2% | 49.6% | 3.6% | AMR |
| 2010s | 60.7% | 68.8% | 8.1% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, AMR or Korea?
- Korea, at 74.7% against 62.0% in AMR as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between AMR and Korea?
- 12.7%, with Korea ahead.
- How many years of comparable data are there for AMR and Korea?
- 30 years are reported by both, from 1990 to 2019.
- How do AMR and Korea rank globally for hypertension treatment coverage among adults aged 30-79 with?
- AMR ranks 2nd and Korea ranks 2nd of 17 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.